載入...
Single-dose liposomal amphotericin B (AmBisome(®)) for the treatment of Visceral Leishmaniasis in East Africa: study protocol for a randomized controlled trial
BACKGROUND: AmBisome(® )is an efficacious, safe anti-leishmanial treatment. There is growing interest in its use, either as a single dose or in combination treatments. In East Africa, the minimum optimal single-dosage has not been identified. METHODS/DESIGN: An open-label, 2-arm, non-inferiority, mu...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3061925/ https://ncbi.nlm.nih.gov/pubmed/21375777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-12-66 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|